1-4 of 4
Federico Mazzon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Decisional Role of Interim PET in Relapsed/Refractory Classical Hodgkin Lymphoma Treated with Begev Chemotherapy As First Salvage

Chiara Rusconi, Francesca Ricci, Vincenzo Marasco, Vittorio Ruggero Zilioli, Eleonora Calabretta, Anna Guidetti, Cristina Muzi, Federico Mazzon, Margherita Smania, Martina Sollini, Sara Iadecola, Erika Meli, Marcello Rodari, Emanuele Ravano, Roberto Cairoli, Paolo Corradini, Armando Santoro
Journal: Blood
Blood (2022) 140 (Supplement 1): 6581–6583.
https://doi.org/10.1182/blood-2022-165948
Published: 2022
Journal Articles

Luspatercept in Combination with Recombinant-Erythropoietin in MDS RS Patients: Stimulating Early and Late Erythropoiesis

Francesco Versino, Marta Bortolotti, Beatrice Ferrari, Lorenzo Rizzo, Federico Mazzon, Marta Riva, Paola Bianchi, Wilma Barcellini, Bruno Fattizzo
Journal: Blood
Blood (2022) 140 (Supplement 1): 12323–12324.
https://doi.org/10.1182/blood-2022-158279
Published: 2022
Journal Articles

Luspatercept in MDS with Ring Sideroblasts: A Real-Life Multicenter Experience from a Named Patient Program

Marta Riva, Bruno Fattizzo, Lorenzo Rizzo, Federico Mazzon, Juri Alessandro Giannotta, Wilma Barcellini, Roberto Cairoli
Journal: Blood
Blood (2021) 138 (Supplement 1): 4659.
https://doi.org/10.1182/blood-2021-153179
Published: 2021
Journal Articles

Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) Patients: A Retrospective Analysis of Eligibility Criteria for CAR-T Cell Therapy

Alice Di Rocco, Arianna Di Rocco, MD, Alessio Farcomeni, PhD, Luigi Petrucci, MD, Giulia De Luca, MD, Federico Mazzon, MD, Maurizio Martelli, MD, Robin Foà, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2888.
https://doi.org/10.1182/blood-2019-131417
Published: 2019